# DuplexSeq

Type: Technology

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/duplexseq
Canonical HTML page: https://gethealthbrief.com/entity/duplexseq

## Recent coverage (1 stories)

### Scantox Bolsters Genetic Toxicology via TwinStrand DuplexSeq Acquisition
2026-02-26 11:29:52 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Scantox has acquired the DuplexSeq™ nonclinical genomics safety business from TwinStrand Biosciences, integrating ultra-sensitive DNA sequencing into its pre-clinical service portfolio. The move positions Scantox as a leader in next-generation genetic toxicology, offering 10,000x higher sensitivity than standard sequencing methods.
Full story: https://gethealthbrief.com/story/scantox-acquires-twinstrand-duplexseq-genomics-safety

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.